by McDermott + Bull | Feb 1, 2023 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
MEDTECH + LIFE SCIENCES OUTLOOK IN 2023 2022 was an interesting year, to say the least. It was the tale of two markets. After the extremely volatile years of 2020 and 2021, no one could have predicted the sheer amount of momentum that lay ahead in 2022. The economy...
by McDermott + Bull | Nov 24, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
Heading into 2022, many expected the rapid continuation of strong initial public offerings (IPOs) and merger + acquisition (M+A) activity. Wow, that was off. The underestimated implications of supply chain issues, geopolitical concerns, and Federal Trade Commission...
by McDermott + Bull | May 27, 2022 | Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
THE STATE OF WOMEN IN THE HEALTHCARE + LIFE SCIENCES WORKFORCE McKinsey & Company is one of the top companies when it comes to collecting data, identifying trends, and suggesting actions and strategies that address potential issues. The article, “Women in...
by McDermott + Bull | Feb 3, 2022 | Article, Healthcare + Life Sciences, Healthcare + Life Sciences Article, Ken Dropiewski, Ken Dropiewski Article
LIFE SCIENCES + HEALTHCARE OUTLOOK IN 2022 When the J.P. Morgan Healthcare Conference took place last January, I skipped it, optimistically thinking that things would be different and safer the following year. Shortly before this year’s conference, it was announced...
